Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Purchased by Deutsche Bank AG

Deutsche Bank AG grew its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 51.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 43,809 shares of the company's stock after purchasing an additional 14,929 shares during the quarter. Deutsche Bank AG owned about 0.09% of Prestige Consumer Healthcare worth $3,421,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Kestra Investment Management LLC purchased a new position in Prestige Consumer Healthcare in the 4th quarter worth approximately $27,000. CIBC Private Wealth Group LLC lifted its stake in Prestige Consumer Healthcare by 48.9% in the 4th quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock worth $34,000 after purchasing an additional 152 shares in the last quarter. Headlands Technologies LLC purchased a new stake in shares of Prestige Consumer Healthcare during the 4th quarter valued at approximately $40,000. Johnson Financial Group Inc. purchased a new stake in shares of Prestige Consumer Healthcare during the 4th quarter valued at approximately $93,000. Finally, Huntington National Bank raised its position in shares of Prestige Consumer Healthcare by 133.2% during the 4th quarter. Huntington National Bank now owns 1,481 shares of the company's stock valued at $116,000 after buying an additional 846 shares during the period. 99.95% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have recently commented on PBH. Canaccord Genuity Group lifted their price target on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a "buy" rating in a research report on Friday, February 7th. DA Davidson lifted their price target on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a "buy" rating in a research report on Friday, February 7th. Wall Street Zen raised shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, May 17th. Royal Bank of Canada raised shares of Prestige Consumer Healthcare to a "hold" rating in a research report on Thursday, May 8th. Finally, Oppenheimer lifted their price target on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an "outperform" rating in a research report on Thursday, February 13th. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $93.33.

Prestige Consumer Healthcare Trading Up 1.1%

NYSE PBH traded up $0.97 on Monday, reaching $85.98. The stock had a trading volume of 341,432 shares, compared to its average volume of 297,874. The firm has a market capitalization of $4.25 billion, a price-to-earnings ratio of 20.14, a P/E/G ratio of 2.69 and a beta of 0.44. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56. Prestige Consumer Healthcare Inc. has a 12-month low of $62.35 and a 12-month high of $90.04. The stock has a fifty day moving average price of $83.56 and a two-hundred day moving average price of $82.34.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $1.32 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.30 by $0.02. The company had revenue of $296.52 million for the quarter, compared to analyst estimates of $289.36 million. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. The firm's quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.02 earnings per share. As a group, sell-side analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Insider Buying and Selling at Prestige Consumer Healthcare

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of the business's stock in a transaction on Monday, March 10th. The shares were sold at an average price of $90.00, for a total value of $151,020.00. Following the completion of the transaction, the senior vice president now owns 17,157 shares in the company, valued at $1,544,130. The trade was a 8.91% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 1.60% of the stock is owned by corporate insiders.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.